Heart Failure Management: SGLT2i and GLP-1 RA Mechanism of Action

September 20, 2022
Guest: Kim Newlin, MSN, ANP, FPCNA and Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA

Often prescribed for obesity, SGLT2is and GLP-1 RAs have a role in heart failure management. Learn about their mechanisms of action, and how their use extends beyond weight loss to cardioprotective and renal protective properties. Join us with guests Kim Newlin, MSN, ANP, FPCNA, of Sutter Roseville Medical Center in Northern California, and Colleen McIlvennan, PhD, DNP, ANP, FAHA, FHFSA, from the University of Colorado in Denver.

You can earn 0.5 contact hours and .05 pharmacology hours from listening to this podcast episode and completing the course components.

This podcast is supported by independent educational grants from Merck Sharpe Dohme Corporation and the Pfizer-Merck Alliance.

Episode Resources

Subscribe Today

Don't miss an episode! Listen to the Heart to Heart Nurses podcast on your favorite podcast listening service.

Other Episodes

Stroke: Risk Factors and Prevention
March 21, 2023
Chloe Villavaso, MN, APRN, ACNS-BC, FPCNA, AACC
Advocacy for Patients with Obesity
March 7, 2023
Starlin Haydon-Greatting and Garth Reynolds
The Impact of Obesity on CVD Outcomes
February 21, 2023
Advocacy and Nursing
February 7, 2023
Laura Hayman, PhD, RN, FPCNA, FAAN
Women’s Health: Maternal Mortality & CVD
January 31, 2023
Erin Poe Ferranti, PhD, MPH, RN, CDCES, FAHA, FPCNA, and Abha Khandelwal MD, MS , FACC